Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.KYNB · Entity 7431 | Director · CEO | September 06, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date September 06, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,796 |
Reported balance
After 2026-09-06 transaction · row 1
1 source rowRow 1 · 2026-09-06 · Tax withholding · Disposed 209 · Balance 26,796 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 40 |
Reported balance
Holding disclosure · report date 2026-09-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 40 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2026 Filed Sep 10, 2026 00:42 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | Tax withholdingCommon Stock | 209 | $8.55 | $1,786.95 |
DisclosureSEC source: 0001815638-26-000011 · form4-09102026_120924.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,796 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 21:46 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | Tax withholdingCommon Stock | 198 | $6.71 | $1,328.58 |
DisclosureSEC source: 0001815638-26-000009 · form4-06092026_090658.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,005 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| May 14, 2026 Filed May 18, 2026 12:00 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | PurchaseCommon Stock | 2,800 | $7.09 | $19,852.00 |
DisclosureSEC source: 0001815638-26-000005 · form4-05182026_080501.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,203 Read SEC document |
| May 14, 2026 Filed May 19, 2026 19:08 UTC Amendment | KYNTRA BIO, INC. KYNB · Entity 7431 | PurchaseCommon Stock | 2,800 | $7.09 | $19,852.00 |
DisclosureSEC source: 0001815638-26-000007 · form4a-05192026_070512.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,203 Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:41 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | Tax withholdingCommon Stock | 277 | $6.84 | $1,894.68 |
DisclosureSEC source: 0001815638-26-000003 · form4-03102026_090328.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,403 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 02:08 UTC | KYNTRA BIO, INC. KYNB · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0001815638-26-000002 · form4-02062026_020215.xml · derivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2036-02-02 F1 · derivative.exercise_date: The option vests in equal amount quarterly over 4 years measured from 2/3/2026. Read SEC document |
| December 06, 2025 Filed Dec 9, 2025 21:10 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 259 | $8.42 | $2,180.78 |
DisclosureSEC source: 0001815638-25-000005 · form4-12092025_091206.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,680 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 17, 2025 Filed Nov 17, 2025 21:42 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | PurchaseCommon Stock | 2,700 | $9.10 | $24,569.73 |
DisclosureSEC source: 0001815638-25-000004 · form4-11172025_091148.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,939 Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 21:42 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | PurchaseCommon Stock | 1,000 | $9.18 | $9,180.00 |
DisclosureSEC source: 0001815638-25-000004 · form4-11172025_091148.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,239 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 23:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 248 | $12.10 | $3,000.80 |
DisclosureSEC source: 0001415889-25-024012 · form4-09092025_110909.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,239 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 06, 2025 Filed Sep 9, 2025 23:25 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 246 | $7.83 | $1,926.80 |
DisclosureSEC source: 0001415889-25-024012 · form4-09092025_110909.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,487 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 13:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | PurchaseCommon Stock | 145,000 | $0.35 | $50,663.00 |
DisclosureSEC source: 0001415889-25-008872 · form4-03252025_090301.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 543,329 F1 · price: Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.34 to $0.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 00:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 367 | $0.39 | $143.13 |
DisclosureSEC source: 0001415889-25-007459 · form4-03082025_120348.xml · nonDerivative · entry 3 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,329 F3 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 00:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007459 · form4-03082025_120348.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,696 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 00:03 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 22,038 | $0.39 | $8,594.82 |
DisclosureSEC source: 0001415889-25-007459 · form4-03082025_120348.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,915 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| January 09, 2025 Filed Jan 10, 2025 23:15 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 1,300,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001415889-25-001310 · form4-01102025_110107.xml · derivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300,000 Underlying: Common Stock · 1,300,000 shares Expires 2035-01-08 F1 · derivative.exercise_date: The option vests in equal amount quarterly over 4 years measured from 1/9/2025. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 01:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,363 | $0.34 | $808.38 |
DisclosureSEC source: 0001415889-24-028743 · form4-12092024_081203.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,953 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,363 | $0.39 | $921.57 |
DisclosureSEC source: 0001415889-24-023089 · form4-09092024_080904.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,316 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 20,840 | $0.47 | $9,794.80 |
DisclosureSEC source: 0001415889-24-020745 · form4-08052024_080844.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,679 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 22, 2024 Filed Jun 25, 2024 20:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 782 | $1.13 | $883.66 |
DisclosureSEC source: 0001415889-24-018145 · form4-06252024_040601.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,519 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 23:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,255 | $1.19 | $2,683.45 |
DisclosureSEC source: 0001415889-24-016079 · form4-06072024_070602.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,301 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| May 01, 2024 Filed May 2, 2024 23:46 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 20,840 | $1.17 | $24,382.80 |
DisclosureSEC source: 0001415889-24-012091 · form4-05022024_110520.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,556 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 21:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 782 | $2.58 | $2,017.56 |
DisclosureSEC source: 0001415889-24-009048 · form4-03252024_090320.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,396 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 23:06 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | PurchaseCommon Stock | 50,000 | $1.91 | $95,470.00 |
DisclosureSEC source: 0001415889-24-007570 · form4-03112024_110334.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,178 Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 326 | $1.87 | $609.62 |
DisclosureSEC source: 0001415889-24-007453 · form4-03092024_120313.xml · nonDerivative · entry 3 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,178 F3 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007453 · form4-03092024_120313.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,504 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2024. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 4,209 | $1.87 | $7,870.83 |
DisclosureSEC source: 0001415889-24-007453 · form4-03092024_120313.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,723 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 834,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001415889-24-005156 · form4-02242024_010232.xml · derivative · entry 3 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834,000 Underlying: Common Stock · 834,000 shares Expires 2034-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 166,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005156 · form4-02242024_010232.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,932 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 01:08 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 23,490 | $2.37 | $55,671.30 |
DisclosureSEC source: 0001415889-24-002750 · form4-02062024_010229.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,932 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 22, 2023 Filed Dec 27, 2023 00:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 819 | $0.76 | $622.44 |
DisclosureSEC source: 0001209191-23-059713 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,422 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 06, 2023 Filed Dec 11, 2023 21:19 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,680 | $0.58 | $974.40 |
DisclosureSEC source: 0001209191-23-058051 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,241 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 21,841 | $0.55 | $11,949.21 |
DisclosureSEC source: 0001209191-23-054320 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,921 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 23:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 819 | $0.79 | $643.98 |
DisclosureSEC source: 0001209191-23-050526 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,762 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 21:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,680 | $0.96 | $1,618.01 |
DisclosureSEC source: 0001209191-23-048815 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,581 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 21:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001209191-23-045215 · doc4.xml · derivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-08-06 F2 · derivative.exercise_date: Twenty-Five percent of the shares subject to the option vest on August 7, 2024 and the remainder vest quarterly in equal installments over the following 3 years, subject to the reporting person's continued service with the company on each such date. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 21:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045215 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,261 F1 · shares: Represents the grant of Restricted Stock Units ("RSUs") that vest quarterly over 1 year from August 1, 2023, subject to the reporting person's continued service with the company on each such date. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:27 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 791 | $16.53 | $13,074.99 |
DisclosureSEC source: 0001209191-23-039700 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,261 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,286 | $17.04 | $21,910.48 |
DisclosureSEC source: 0001209191-23-036066 · doc4.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,395 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 472 | $17.04 | $8,040.80 |
DisclosureSEC source: 0001209191-23-036066 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,681 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. F2 · balance_after: Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 07, 2023 Filed Jun 22, 2023 22:32 UTC Amendment | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,286 | $17.04 | $21,910.48 |
DisclosureSEC source: 0001209191-23-039157 · doc4a.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,052 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| June 07, 2023 Filed Jun 22, 2023 22:32 UTC Amendment | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 472 | $17.04 | $8,040.80 |
DisclosureSEC source: 0001209191-23-039157 · doc4a.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,338 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. F2 · balance_after: Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 23, 2023 Filed Mar 25, 2023 00:27 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 905 | $18.71 | $16,932.55 |
DisclosureSEC source: 0001209191-23-021138 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,653 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 20, 2023 Filed Mar 29, 2023 21:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021539 · doc4.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 1,000 F1 · balance_after: The share total in column 5 reflects ownership as of March 28, 2023. Read SEC document |
| March 20, 2023 Filed Mar 29, 2023 21:05 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 2,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021539 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,310 F1 · balance_after: The share total in column 5 reflects ownership as of March 28, 2023. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 4,731 | $20.20 | $95,553.43 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 5 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,558 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,938 | $20.20 | $59,339.67 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 4 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,289 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 9,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 3 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,227 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCOmmon Stock | 5,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,889 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:53 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,265 | $21.16 | $132,541.71 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,090 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.